[go: up one dir, main page]

EP1819722A4 - Modulation de l'ovulation - Google Patents

Modulation de l'ovulation

Info

Publication number
EP1819722A4
EP1819722A4 EP05823157A EP05823157A EP1819722A4 EP 1819722 A4 EP1819722 A4 EP 1819722A4 EP 05823157 A EP05823157 A EP 05823157A EP 05823157 A EP05823157 A EP 05823157A EP 1819722 A4 EP1819722 A4 EP 1819722A4
Authority
EP
European Patent Office
Prior art keywords
ovulation
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05823157A
Other languages
German (de)
English (en)
Other versions
EP1819722A1 (fr
Inventor
Jennifer Lee Juengel
Kenneth Pattrick Mcnatty
Lloyd Gary Moore
Robert Syndecombe Bower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AgResearch Ltd
Original Assignee
AgResearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ53694304A external-priority patent/NZ536943A/en
Application filed by AgResearch Ltd filed Critical AgResearch Ltd
Publication of EP1819722A1 publication Critical patent/EP1819722A1/fr
Publication of EP1819722A4 publication Critical patent/EP1819722A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05823157A 2004-12-02 2005-12-02 Modulation de l'ovulation Withdrawn EP1819722A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NZ53694304A NZ536943A (en) 2004-12-02 2004-12-02 Modulation of ovulation
NZ53903905 2005-03-24
NZ54117005 2005-07-08
PCT/NZ2005/000313 WO2006059913A1 (fr) 2004-12-02 2005-12-02 Modulation de l'ovulation

Publications (2)

Publication Number Publication Date
EP1819722A1 EP1819722A1 (fr) 2007-08-22
EP1819722A4 true EP1819722A4 (fr) 2009-09-09

Family

ID=36565307

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05823157A Withdrawn EP1819722A4 (fr) 2004-12-02 2005-12-02 Modulation de l'ovulation

Country Status (6)

Country Link
EP (1) EP1819722A4 (fr)
JP (1) JP2008521891A (fr)
AU (1) AU2005310356A1 (fr)
BR (1) BRPI0518809A2 (fr)
CA (1) CA2589898A1 (fr)
WO (1) WO2006059913A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130022A1 (fr) * 2005-05-30 2006-12-07 Agresearch Limited Modulation de l'ovulation au moyen d'agonistes et d'antagonistes de bmprii
US8530235B2 (en) 2005-07-18 2013-09-10 Adelaide Research & Innovation Pty Ltd. Medium that supports culture of an oocyte and modulation of granulosa cell apoptosis
BRPI0706173C1 (pt) * 2007-11-23 2011-02-22 Brasil Pesquisa Agropec metodo para identificação massal de animais com aumento na prolificidade
US11702457B2 (en) 2018-05-09 2023-07-18 Monash University Agent and method for enhancing fertility

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999017797A1 (fr) * 1997-10-06 1999-04-15 The Johns Hopkins University School Of Medicine Utilisation du facteur de differentiation de la croissance (gdf-9) comme contraceptif
US6191261B1 (en) * 1993-01-12 2001-02-20 The Johns Hopkins University School Of Medicine Growth differentiation factor-9 antibodies and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191261B1 (en) * 1993-01-12 2001-02-20 The Johns Hopkins University School Of Medicine Growth differentiation factor-9 antibodies and methods
WO1999017797A1 (fr) * 1997-10-06 1999-04-15 The Johns Hopkins University School Of Medicine Utilisation du facteur de differentiation de la croissance (gdf-9) comme contraceptif

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JUENGEL J L ET AL: "Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep", BIOLOGY OF REPRODUCTION, SOCIETY FOR THE STUDY OF REPRODUCTION, CHAMPAIGN, IL, US, vol. 67, 4 October 2002 (2002-10-04), pages 1777 - 1789, XP002999768, ISSN: 0006-3363 *
MCNATTY KP ET AL: "The Effects of Immunizing Sheep with Different BMP15 or GDF9 Peptide Sequences on Ovarian Follicular Activity and Ovulation Rate", BIOLOGY OF REPRODUCTION, vol. 76, 8 November 2006 (2006-11-08), pages 552 - 560, XP002538978, DOI: 10.1095/biolreprod.106.054361 *
See also references of WO2006059913A1 *

Also Published As

Publication number Publication date
JP2008521891A (ja) 2008-06-26
AU2005310356A1 (en) 2006-06-08
WO2006059913A9 (fr) 2008-05-22
BRPI0518809A2 (pt) 2008-12-09
CA2589898A1 (fr) 2006-06-08
EP1819722A1 (fr) 2007-08-22
WO2006059913A1 (fr) 2006-06-08

Similar Documents

Publication Publication Date Title
NO2017058I1 (no) HPV 58 L1 protein
NO2017012I1 (no) HPV 45 L1 protein
EP1633307A4 (fr) Modulation de l'expression de survivine
DE60316652D1 (de) Endoskop
DE60336213D1 (de) Chirurgisches klammergerät
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
EP1746141A4 (fr) Composition d' epaississement
DK1646311T3 (da) Endoskopisk fastgörelsesindretning
EP1827473A4 (fr) Modulateurs de toxicite de l'alpha-synucleine
FR2847154B3 (fr) Architecture amovible de fausse-dent
EP1685147A4 (fr) Modulation de l'expression du sglt2
DE602004002056D1 (de) Fixation d'un coussin gonflable
EP1924288A4 (fr) Lignées cellulaires entièrement humaines partenaires de fusion d'hybridomes
DE60326190D1 (de) des Körpers
FR2875398B1 (fr) Implant articulaire d'interposition
EP1714656A4 (fr) Preparation de l'ed-71
FR2845267B1 (fr) Kit cutane de diagnostic de l'atopie
DE10309491B8 (de) Chirurgischer Clip
EP1819722A4 (fr) Modulation de l'ovulation
EP1809646A4 (fr) Riboswitches de glycine, méthodes d'utilisation et compositions s'utilisant avec les riboswitches
EP1646401A4 (fr) Anticorps humains specifiques
EP1756276A4 (fr) Vecteur d'expression de crustace
FR2864540B1 (fr) Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase-related-protein 1 comme agents depigmentants
ITSV20040008A1 (it) Dottor "g"
FR2852042B1 (fr) Piece d'aretier

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070626

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 15/08 20060101ALI20090730BHEP

Ipc: A61K 39/395 20060101ALI20090730BHEP

Ipc: C07K 14/495 20060101ALI20090730BHEP

Ipc: C07K 14/51 20060101ALI20090730BHEP

Ipc: C07K 16/22 20060101ALI20090730BHEP

Ipc: A61K 38/10 20060101ALI20090730BHEP

Ipc: C07K 7/08 20060101AFI20060619BHEP

Ipc: C07K 14/475 20060101ALI20090730BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20090807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091105